![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
First report of dolutegravir unbound plasma concentrations
during pregnancy in HIV-positive women
|
|
|
Reported by Jules Levin
19th International Workshop on Clinical Pharmacology of Antiviral Therapy 2018, 22-24 May 2018 Baltimore, USA
Bollen P1, Colbers A1, Schalkwijk S1,2, Velthoven- Graafland K1, Konopnicki D3, Weizsacker K4, Hidalgo Tenorio C5, van Crevel R6, Burger D1
1Radboudumc, Department of Pharmacy and Radboud Institute for Health Sciences, Nijmegen, Netherlands, 2Radboudumc, Department of Pharmacology and Toxicology, Nijmegen, Netherlands, 3Saint-Pierre University Hospital, Brussels, Belgium, 4Charite Universitatsmedizin, Department of Obstetrics, Berlin, Germany, 5Hospital Universitario Virgen de las Nieves Granada, Granada, Spain, 6Radboudumc, Department of Internal Medicine and Radboud Institute for Health Sciences, Nijmegen, Netherlands
![0525181](../images%20/052618/052618-1/0525181.gif)
![0525182](../images%20/052618/052618-1/0525182.gif)
![0525183](../images%20/052618/052618-1/0525183.gif)
![0525184](../images%20/052618/052618-1/0525184.gif)
![0525185](../images%20/052618/052618-1/0525185.gif)
![0525186](../images%20/052618/052618-1/0525186.gif)
![0525187](../images%20/052618/052618-1/0525187.gif)
![0525188](../images%20/052618/052618-1/0525188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|